iRhythm Technologies, Inc. financial data

Symbol
IRTC on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
699 8 Th Street, Suite 600, San Francisco, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 20, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 650 % +158%
Quick Ratio 14.6 % -4.69%
Debt-to-equity 942 % +872%
Return On Equity -129 % -128%
Return On Assets -12.4 % +56.9%
Operating Margin -19.5 % +23.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 31.4M shares
Common Stock, Shares, Outstanding 31.4M shares +1.42%
Entity Public Float 3.3B USD +3.13%
Common Stock, Value, Issued 31K USD 0%
Weighted Average Number of Shares Outstanding, Basic 31.2M shares +2.19%
Weighted Average Number of Shares Outstanding, Diluted 31.2M shares +2.19%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 592M USD +20.1%
Cost of Revenue 184M USD +14.6%
Research and Development Expense 68.4M USD +30%
Operating Income (Loss) -116M USD +7.72%
Nonoperating Income (Expense) 4.31M USD +532%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -113M USD +8.1%
Income Tax Expense (Benefit) 565K USD -24.7%
Net Income (Loss) Attributable to Parent -113M USD +8.2%
Earnings Per Share, Basic -3.63 USD/shares +10.1%
Earnings Per Share, Diluted -3.63 USD/shares +10.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 420M USD +1060%
Marketable Securities, Current 116M USD +18.8%
Cash, Cash Equivalents, and Short-term Investments 317M USD +188%
Accounts Receivable, after Allowance for Credit Loss, Current 79.9M USD +30%
Inventory, Net 14M USD +0.47%
Assets, Current 646M USD +180%
Property, Plant and Equipment, Net 125M USD +20.1%
Operating Lease, Right-of-Use Asset 47.6M USD -3.56%
Goodwill 862K USD 0%
Other Assets, Noncurrent 41.9M USD -7.08%
Assets 931M USD +115%
Accounts Payable, Current 7.22M USD +30.3%
Accrued Liabilities, Current 84.9M USD +1.85%
Contract with Customer, Liability, Current 2.93M USD -11.3%
Liabilities, Current 111M USD +3.31%
Operating Lease, Liability, Noncurrent 74.6M USD -6.42%
Other Liabilities, Noncurrent 8.58M USD +748%
Liabilities 841M USD +277%
Accumulated Other Comprehensive Income (Loss), Net of Tax 165K USD
Retained Earnings (Accumulated Deficit) -759M USD -17.5%
Stockholders' Equity Attributable to Parent 90.9M USD -56.7%
Liabilities and Equity 931M USD +115%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -52M USD -69.2%
Net Cash Provided by (Used in) Financing Activities 505M USD +55661%
Net Cash Provided by (Used in) Investing Activities 40M USD +947%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 31.6M shares +2.16%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 493M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 428M USD +1083%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.6M USD +135%
Deferred Tax Assets, Valuation Allowance 243M USD +11.4%
Deferred Tax Assets, Gross 255M USD +11%
Operating Lease, Liability 90.5M USD -4.65%
Payments to Acquire Property, Plant, and Equipment 9.78M USD +16.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -113M USD +8.21%
Lessee, Operating Lease, Liability, to be Paid 116M USD -8.05%
Property, Plant and Equipment, Gross 196M USD +27%
Operating Lease, Liability, Current 15.9M USD +4.67%
Lessee, Operating Lease, Liability, to be Paid, Year Two 16.7M USD +6.68%
Lessee, Operating Lease, Liability, to be Paid, Year One 15.1M USD +4.83%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 25.4M USD -18.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 17.1M USD +6.19%
Deferred Tax Assets, Operating Loss Carryforwards 133M USD +4.49%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 6.8M USD +17.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 17M USD +3.15%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 20.7M USD +27%
Deferred Tax Assets, Net of Valuation Allowance 12.4M USD +2.77%
Share-based Payment Arrangement, Expense 76M USD -1.59%
Interest Expense 5.56M USD +81.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%